Loading clinical trials...
Loading clinical trials...
A Double Blind (Sponsor Open) Placebo-controlled, Stratified, Parallel Group Study to Evaluate the Efficacy and Safety of Repeat Doses of GSK3772847 in Participants With Moderate to Severe Asthma With Allergic Fungal Airway Disease (AFAD)
Conditions
Interventions
GSK3772847
Placebo
Locations
18
France
GSK Investigational Site
Brest, France
GSK Investigational Site
Montpellier, France
GSK Investigational Site
Nantes, France
GSK Investigational Site
Amsterdam, Netherlands
GSK Investigational Site
Izhevsk, Russia
GSK Investigational Site
Kemerovo, Russia
Start Date
April 18, 2018
Primary Completion Date
October 9, 2019
Completion Date
January 6, 2020
Last Updated
October 23, 2020
NCT02327897
NCT07486401
NCT07219173
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions